|
Follow the links below to find information on hormonal treatments for breast cancer.
Reviewed June 2007
Printer friendly page
| Results 1 to 13 displayed. |
| Title: |
Phytoestrogens and breast cancer
|
| Publisher: |
The Jean Hailes Foundation for Women's Health
|
| Description: |
There has been much speculation about phytoestrogens - particularly soy products, and breast cancer risk. This is mainly based on the idea that because these foods contain oestrogen, they can stimulate the breast tissue like our own body's oestrogen or prescribed oestrogen might.
|
| Date: |
Oct 2007
|
| Title: |
Side effects of hormonal therapies
|
| Publisher: |
National Breast Cancer Centre (NBCC)
|
| Description: |
Hormonal therapies have some side effects in common, and others that differ. Also, different women may respond differently to the same treatment.
|
| Date: |
Nov 2006
|
| Title: |
Deciding whether to use hormonal therapies
|
| Publisher: |
National Breast Cancer Centre (NBCC)
|
| Description: |
Hormonal therapies are usually recommended for women who have hormone receptors on their breast cancer cells. Your doctor will also consider the risk of your breast cancer coming back, and your general health.
|
| Date: |
Nov 2006
|
| Title: |
Types of hormonal therapies
|
| Publisher: |
National Breast Cancer Centre (NBCC)
|
| Description: |
There are different ways of reducing the level of female hormones in the body: anti-oestrogens, aromatase inhibitors and anti-ovarian treatments.
|
| Date: |
Nov 2006
|
| Title: |
What are hormonal therapies?
|
| Publisher: |
National Breast Cancer Centre (NBCC)
|
| Description: |
Hormonal therapies (also called endocrine therapies) are drugs used to treat women with breast cancer who have hormone receptors on their breast cancer cells. Hormone receptors are proteins on the surface of a cell that allow the cell to bind to hormones.
|
| Date: |
Nov 2006
|
| Title: |
Breast cancer and oestrogen
|
| Publisher: |
Better Health Channel
|
| Description: |
Around 60 per cent of breast cancers are sensitive to the female sex hormone oestrogen. The growth of these cancers can be minimised by taking drugs that block the action of oestrogen in the breast tissue.
|
| Date: |
Oct 2006
|
| Title: |
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Advanced (or metastatic) breast cancer is cancer that has spread beyond the breast. Endocrine therapy removes the influence of oestrogen on breast cancer cells and can prevent the cells from growing and spreading in early breast cancer if the tumour is ...
|
| Date: |
Oct 2006
|
| Title: |
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Breast cancer is the most common cancer in women. If the cancer has spread beyond the breast (metastatic disease), treatments include chemotherapy (anti-cancer drugs) and endocrine therapy (also known as hormonal treatment). Endocrine therapy is mainly ...
|
| Date: |
Feb 2003
|
| Title: |
Clinical practice guidelines for the management of advanced breast cancer
|
| Publisher: |
National Health and Medical Research Council (NHMRC)
|
| Description: |
These guidelines have been developed by a multidisciplinary working party, and are primarily intended for use by all health professionals involved in the management of women with advanced breast cancer. They aim to provide material that will be helpful and supportive to those managing the difficult range of problems that may present.
|
| Date: |
Jan 2001
|
| Results 1 to 13 displayed. |
|